Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol)
The DOI matches its Crossref record.
Abstract
1. Plasma glucose and insulin concentrations were measured during oral (OGTT) and intravenous (IVGTT) glucose tolerance tests in nine patients off- and on-treatment with the anabolic steroid, methandienone (Dianabol). 2. On-treatment, the tolerance tests showed a markedly increased insulin response accompanied by impairment of glucose tolerance, characteristics normally attributed to insulin resistance. However, fasting plasma glucose (FPG) and insulin (FPI) concentrations were significantly reduced, whereas the pattern normally associated with insulin resistance is for both to be raised. 3. IVGTT glucose and insulin profiles were analysed using an algorithm derived from the minimal models of glucose and insulin dynamics originally proposed by R. Bergman and co-workers. Measures for the following parameters were thus obtained: Si, the sensitivity of glucose disposal to insulin; Sg, net insulin independent glucose disposal; ϕ1, the integral concentration of insulin delivered during the first phase of insulin secretion relative to the initial increase in glucose concentration above a model-derived threshold; ϕ2 the sensitivity of the rate of rise of insulin concentration in the second phase of insulin secretion to the concentration of glucose above a model-derived threshold; κ, the fractional clearance rate of insulin; and tl/2, the insulin half-life. 4. Si was significantly reduced on treatment by a factor of 4. Sg, ϕ1, ϕ2 and t1/2 were all significantly increased, and κ was significantly reduced. The increases in Sg and ϕ1 both showed significant correlations with the increase in weight on-treatment. 5. The reduction in FPG and FPI can be explained by the combined effects of the increase in Sg and Dianabol-induced resistance to glucagon. 6. Application of the Bergman models proved to be of value in identifying and quantifying Dianabol-induced insulin resistance. Model-derived parameters of insulin clearance and net insulin independent glucose uptake were also of use in interpreting the changes in glucose and insulin concentrations observed. However, model-derived parameters of pancreatic insulin secretion were likely to have been confounded by reduced hepatic insulin uptake associated with a state of relative insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gender differences in insulin resistance, body composition, and energy balance
Geer, E. B., & Shen, W. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.002 · Cited by 913
WILSON, J. D. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-2-181 · Cited by 427
Androgens, insulin resistance and vascular disease in men
Kapoor, D., Malkin, C. J., Channer, K. S., & Jones, T. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02299.x · Cited by 317
Barrett-Connor, E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-807 · Cited by 281
“In sufficient doses, oral alpha17-alkylated androgens decrease both glucose tolerance and plasma testosterone (30, 36-38).”
BackgroundLiu, P. Y., Swerdloff, R. S., & Veldhuis, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0807 · Cited by 143
Basu, R., Man, C. D., Campioni, M., Basu, A., Nair, K. S., Jensen, M. D., Khosla, S., Klee, G., Toffolo, G., Cobelli, C., et al. (2007) · Diabetes Care · doi:10.2337/dc07-0359 · Cited by 91
Metadata
- Authors
- Godsland, I. F., Shennan, N. M., & Wynn, V.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 1986-12-01
- Volume
- 71
- Issue
- 6
- Pages
- 665-673
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2397452108
- Cited by
- 31
- References
- 0
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.